FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Martin David

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/25/2009 

3. Issuer Name and Ticker or Trading Symbol

REPLIDYNE INC [CSII]

(Last)        (First)        (Middle)

651 CAMPUS DRIVE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
President and CEO /

(Street)

ST. PAUL, MN 55112       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   49172   D  
 

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)     (1) 7/16/2011   Common Stock   71170   $8.83   D  
 
Stock Option (right to buy)     (2) 8/14/2011   Common Stock   38820   $8.83   D  
 
Stock Option (right to buy)     (3) 2/14/2012   Common Stock   349380   $8.83   D  
 
Stock Option (right to buy)     (4) 6/11/2017   Common Stock   90580   $7.90   D  
 
Stock Option (right to buy)     (5) 12/11/2017   Common Stock   242625   $12.15   D  
 

Explanation of Responses:
( 1)  Exercisable: 3,235 each month beginning 8/17/06.
( 2)  Exercisable in three equal installments of 12,940 on 8/15/07, 8/15/08 and 8/15/09.
( 3)  Exercisable: 9,705 each month beginning 3/15/07.
( 4)  Exercisable: 30,194 on 6/12/08 and 30,193 on each of 6/12/09 and 6/12/10.
( 5)  Exercisable: 121,313 on 2/25/10 and 121,312 on 2/25/11.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Martin David
651 CAMPUS DRIVE
ST. PAUL, MN 55112
X
President and CEO

Signatures
/s/John R. Remakel as Attorney-in-Fact for David L. Martin pursuant to Power of Attorney filed herewith. 2/25/2009
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Replidyne (MM) (NASDAQ:RDYN)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Replidyne (MM) Charts.
Replidyne (MM) (NASDAQ:RDYN)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Replidyne (MM) Charts.